Circumvention of multidrug resistance by MS-209, in multidrug-resistant human small-cell lung cancer cells and its synergistic interaction with cyclosporin A or verapamil

Cancer Chemotherapy and Pharmacology

Volumn 42, Issue 6, 1998, Pages 483-490

  Shrivastava, Punya ^a   Hanibuchi, Masaki ^a   Yano, Seiji ^a   Parajuli, Prahlad ^a   Tsuruo, Takashi ^a,b   Sone, Saburo ^a  

^a UNIVERSITY OF TOKUSHIMA   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

Author keywords

Cyclosporin A; MS 209; Multidrug resistance; Small cell lung cancer; Verapamil

Indexed keywords

5 [3 (4 DIPHENYLACETYL 1 PIPERAZINYL) 2 HYDROXYPROPOXY]QUINOLINE; CYCLOSPORIN A; DOXORUBICIN; GLYCOPROTEIN P; QUINOLINE DERIVATIVE; UNCLASSIFIED DRUG; VERAPAMIL; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL; CELL CULTURE; DOSE RESPONSE; DRUG CYTOTOXICITY; HUMAN; HUMAN CELL; LUNG SMALL CELL CANCER; MULTIDRUG RESISTANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANTINEOPLASTIC AGENTS; CARCINOMA, SMALL CELL; CYCLOSPORINE; DRUG RESISTANCE, MULTIPLE; DRUG RESISTANCE, NEOPLASM; DRUG SYNERGISM; HUMANS; LUNG NEOPLASMS; P-GLYCOPROTEIN; QUINOLINES; TUMOR CELLS, CULTURED; VERAPAMIL;

EID: 0031667361     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050849     Document Type: Article

References (36)

1. Baba M, Nakanishi O, Sato W, Saito A, Miyama Y, Yano O, Shimada S, Fukazawa N, Naito M, Tsuruo T (1995) Relationship between multidrug resistant gene expression and multidrug resistant-reversing effect of MS-209 in various tumor cells. Cancer Chemother Pharmacol 36: 361
2. Berenbaum MC (1981) Criteria for analyzing interactions between biologically active agents. In: Klein G, Weinhouse W (eds) Advances in cancer research. Academic Press, New York Berlin Heidelberg, p 269
3. Blackstein ME (1994) Advances in chemotherapy for small cell lung cancer. Semin Oncol 21 [Suppl 1]: 38
4. Carmichael J, DeGraff WG, Gazdar AF, Minna JD, Mitchell JB (1987) Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res 47: 936
5. Chen CJ, Chin JE, Ueda K, Clark DP, Pastan I, Gottesman MM, Roninson IB (1986) Internal duplication and homology with bacterial transport proteins in the mdr1 (P-glycoprotein) gene from multidrug-resistant human cells. Cell 47: 381
6. Cole SPC, Bhardwaj G, Gerlach JH, Mackie JE, Grant CE, Almquist KC, Stewart AG, Kurz EU, Duncan AM, Deeley RG (1992) Overexpression of a transporter gene in a multidrug-resistant human lung cancer cell line. Science 258: 1650
7. Einhorn LH, Crawford J, Birch R, Omura G, Johnson DH, Greco FA (1988) Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer. J Clin Oncol 6: 451
8. Evans WK, Feld R, Murray N, Willan A, Coy P, Osoba D, Shepherd FA, Clark DA, Levin M, MacDonald A, Wilson K., Shelly W, Pater J (1987) Superiority of alternating non-cross-resistant chemotherapy in extensive small cell lung cancer. A multicenter, randomized clinical trial by the National Cancer Institute of Canada. Ann Intern Med 107: 451
9. Ganapathi R, Grabowski D (1983) Enhancement of sensitivity to adriamycin in resistant P388 leukemia by the calmodulin inhibitor trifluoperazine. Cancer Res 43: 3696
10. Germann UA, Ford PJ, Shlyakhter D, Mason VS, Harding MW (1997) Chemosensitization and drug accumulation effects of VX-710, verapamil, cyclosporin A, MS-209 and GF120918 in multidrug resistant HL60/ADR cells expressing the multidrug resistance-associated protein MRP. Anticancer Drugs 8: 141
11. Goldstein LJ, Galski H, Fojo A, Willingham M, Lai SL, Gazdar A, Pirker R, Green A, Crist W, Brodeur GM, Lieber M, Cossman J, Gottesman MM, Pastan I (1989) Expression of a multidrug resistance gene in human cancers. J Natl Cancer Inst 81: 116
12. Heike Y, Hamada H, Inamura N, Sone S, Ogura T, Tsuruo T (1990) Monoclonal anti-P-glycoprotein antibody-dependent killing of multidrug-resistant tumor cells by human mononuclear cells. Jpn J Cancer Res 81: 1155
13. Holzmayer TA, Hilsenbeck S, Von Hoff DD, Roninson IB (1992) Clinical correlates of MDR1 (P-glycoprotein) gene expression in ovarian and small-cell lung carcinomas. J Natl Cancer Inst 84: 1486
14. Hu XF, Martin TJ, Bell DR, Luise de M, Zalcberg JR (1990) Combined use of cyclosporin A and verapamil in modulating multidrug resistance in human leukemia cell lines. Cancer Res 50: 2953
15. Huang-Yang CP, DePinho SG, Greenberger LM, Arceci RJ, Horwitz SB (1989) Progesteron interacts with P-glycoprotein in multidrug-resistant cells and in the endometrium of gravid uterus. J Biol Chem 264: 782
16. Inaba M, Fujikura R, Tsukagoshi S, Sakurai Y (1981) Restored in vitro sensitivity of adriamycin- and vincristine-resistant P388 leukemia with reserpine. Biochem Pharmacol 30: 2191
17. Ishida Y, Shimada Y, Shimoyama M (1990) Synergistic effect of cyclosporin A and verapamil in overcoming vincristine resistance of multidrug-resistant cultured human leukemia cells. Jpn J Cancer Res 81: 834
18. Lenhert M, Dalton WS, Roe D, Emerson S, Salmon SE (1991) Synergistic inhibition by verapamil and quinine of P-glycoprotein-mediated multidrug resistance in human myeloma cell line model. Blood 77: 348
19. Maeda K, Sone S, Ohmoto Y, Ogura T (1991) A novel differentiation antigen on human monocytes that is specifically induced by granulocyte-macrophage colony-stimulating factor or IL-3. J Immunol 146: 3779
20. Minato K, Kanzawa F, Nishio K, Nakagawa K, Fujiwara Y, Saijo N (1990) Characterization of an etoposide-resistant human small-cell lung cancer cell line. Cancer Chemother Pharmacol 26: 313
21. Mirski SE, Gerlach JH, Cole SP (1987) Multidrug resistance in a human small cell lung cancer cell line selected in adriamycin. Cancer Res 47: 2594
22. Naito M, Tsuruo T (1989) Competitive inhibition by verapamil of ATP-dependent high affinity vincristine binding to the plasma membrane of multidrug-resistant K562 cells without calcium ion involvement. Cancer Res 49: 1452
23. Nakagawa M, Akiyama S, Yamaguchi T, Shiraishi N, Ogata J, Kuwano M (1986) Reversal of multidrug resistance by synthetic isoprenoids in the KB human cancer cell line. Cancer Res 46: 4453
24. Nakanishi O, Baba M, Saito A, Yamashita T, Sato W, Abe H, Fukazawa N, Suzuki T, Sato S, Naito M, Tsuruo T (1997) Potentiation of the antitumor activity by a novel quinoline compound, MS-209, in multidrug-resistant solid tumor cell lines. Oncol Res 9: 61
25. Ohmori T, Morikage T, Sugikoto Y, Fujiwara Y, Kasahara K, Nishio K, Ohta S, Sasaki Y, Takahashi T, Saijo N (1993) The mechanism of the difference in cellular uptake of platinum derivatives in non-small cell lung cancer cell line (PC-14) and its cisplatin-resistant subline (PC-14 CDDP). Jpn J Cancer Res 84: 83
26. Ramu A, Glaubiger D, Fuks Z (1984) Reversal of acquired resistance to doxorubicin in P388 murine leukemia cells by tamoxifen and other triparanol analogues. Cancer Res 44: 4392
27. Sato W, Fukazawa N, Nakanishi O, Baba M, Suzuki T, Yano O, Naito M, Tsuruo T (1995) Reversal of multidrug resistance by a novel quinoline derivative. MS-209. Cancer Chemother Pharmacol 35: 271
28. Shiraishi N, Akiyama S, Nakagawa M, Kobayashi M, Kuwano M (1987) Effect of bisbenzylisoquinoline (biscoclaurine) alkaloids on multidrug resistance in KB human cancer cells. Cancer Res 47: 2413
29. Slapak CA, Mizunuma N, Kufe DW (1994) Expression of the multidrug resistance associated protein and P-glycoprotein in doxorubicin-selected human myeloid leukemia cells. Blood 84: 3113
30. Tsuruo T, Iida H, Nojiri M, Tsukugoshi S, Sakurai Y (1983) Circumvention of vincristine and adriamycin resistance in vitro and in vivo by calcium influx blockers. Cancer Res 43: 2905
31. Tsuruo T, Iida H, Kitatani Y, Yokota K, Tsukagoshi S, Sakurai Y (1984) Effects of quinidine and related compounds on cytoloxicity and cellular accumulation of vincristine and adriamycin in drug-resistant tumor cells. Cancer Res 44: 4303
32. Twentyman PR (1992) Cyclosporins as drug resistance modifiers. Biochem Pharmacol 43: 109
33. Wang YH, Motoji T, Motomura S, Shiozaki H, Tsuruo T, Mizoguchi H (1997) Recovery of drug sensitivity by MS-209, a new multidrug resistance-reversing agent, on acute myelogenous leukemic blasts and K562 cells resistant to adriamycin cell line. Eur J Haematol 58: 186
34. Yano S, Sone S, Nishioka Y, Naito M, Tsuruo T, Ogura T (1994) Cyclosporin A enhances susceptibility of multi-drug resistant human cancer cells to anti-P-glycoprotein antibody-dependent cytotoxicity of monocytes, but not of lymphocytes. Jpn J Cancer Res 85: 194
35. Yonei T, Ohnoshi T, Hiraki S, Ueoka H, Kiura K, Moritaka T, Shibayama T, Tabata M, Segawa Y, Takigawa N, Kimura I (1993) Antitumor activity of platinum analogs against human lung cancer cell lines and tumor specimens. Acta Med Okayama 47: 233
36. Zamora JM, Beck WT (1986) Chloroquine enhancement of anticancer drug cytotoxicity in multiple drug resistant human leukemic cells. Biochem Pharmacol 35: 4303